132 related articles for article (PubMed ID: 14972750)
21. Studies on the mechanism of stabilization of partially phosphorothioated oligonucleotides against nucleolytic degradation.
Uhlmann E; Ryte A; Peyman A
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):345-50. PubMed ID: 9303186
[TBL] [Abstract][Full Text] [Related]
22. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells.
Li B; Hughes JA; Phillips MI
Neurochem Int; 1997 Sep; 31(3):393-403. PubMed ID: 9246681
[TBL] [Abstract][Full Text] [Related]
23. Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion.
Broaddus WC; Prabhu SS; Gillies GT; Neal J; Conrad WS; Chen ZJ; Fillmore H; Young HF
J Neurosurg; 1998 Apr; 88(4):734-42. PubMed ID: 9525721
[TBL] [Abstract][Full Text] [Related]
24. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide.
Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F
J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139
[TBL] [Abstract][Full Text] [Related]
25. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.
Beltinger C; Saragovi HU; Smith RM; LeSauteur L; Shah N; DeDionisio L; Christensen L; Raible A; Jarett L; Gewirtz AM
J Clin Invest; 1995 Apr; 95(4):1814-23. PubMed ID: 7706488
[TBL] [Abstract][Full Text] [Related]
26. The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Farrell CL; Bready JV; Kaufman SA; Qian YX; Burgess TL
Antisense Res Dev; 1995; 5(3):175-83. PubMed ID: 8785473
[TBL] [Abstract][Full Text] [Related]
27. Biodistribution of 68Ga-labelled phosphodiester, phosphorothioate, and 2'-O-methyl phosphodiester oligonucleotides in normal rats.
Lendvai G; Velikyan I; Bergström M; Estrada S; Laryea D; Välilä M; Salomäki S; Långström B; Roivainen A
Eur J Pharm Sci; 2005 Sep; 26(1):26-38. PubMed ID: 15941654
[TBL] [Abstract][Full Text] [Related]
28. Phosphorothioate oligodeoxynucleotides inhibit basic fibroblast growth factor-induced angiogenesis in vitro and in vivo.
Kitajima I; Unoki K; Maruyama I
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):233-9. PubMed ID: 10355829
[TBL] [Abstract][Full Text] [Related]
29. Intracellular routing and inhibitory activity of oligonucleopeptides containing a KDEL motif.
Pichon C; Arar K; Stewart AJ; Dodon MD; Gazzolo L; Courtoy PJ; Mayer R; Monsigny M; Roche AC
Mol Pharmacol; 1997 Mar; 51(3):431-8. PubMed ID: 9058598
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of antisense analogues in the central nervous system.
Szklarczyk A; Kaczmarek L
Neurochem Int; 1997 Sep; 31(3):413-23. PubMed ID: 9246683
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology and toxicology of phosphorothioate oligonucleotides in the mouse, rat, monkey and man.
Iversen PL; Copple BL; Tewary HK
Toxicol Lett; 1995 Dec; 82-83():425-30. PubMed ID: 8597088
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth.
Aoki M; Morishita R; Matsushita H; Hayashi S; Nakagami H; Yamamoto K; Moriguchi A; Kaneda Y; Higaki J; Ogihara T
Hypertension; 1999 Aug; 34(2):192-200. PubMed ID: 10454440
[TBL] [Abstract][Full Text] [Related]
33. Quantitative three-dimensional analysis and diffusion modeling of oligonucleotide concentrations after direct intraparenchymal brain infusion.
Haar PJ; Stewart JE; Gillies GT; Prabhu SS; Broaddus WC
IEEE Trans Biomed Eng; 2001 May; 48(5):560-9. PubMed ID: 11341530
[TBL] [Abstract][Full Text] [Related]
34. Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor.
Robinson CJ; Scott PH; Allan AB; Jess T; Gould GW; Plevin R
Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):123-7. PubMed ID: 8947476
[TBL] [Abstract][Full Text] [Related]
35. Intracellular transport of formaldehyde-treated serum albumin in liver endothelial cells after uptake via scavenger receptors.
Eskild W; Kindberg GM; Smedsrod B; Blomhoff R; Norum KR; Berg T
Biochem J; 1989 Mar; 258(2):511-20. PubMed ID: 2705996
[TBL] [Abstract][Full Text] [Related]
36. Studies on uptake, sub-cellular trafficking and efflux of antisense oligodeoxynucleotides in glioma cells using self-assembling cationic lipoplexes as delivery systems.
Islam A; Handley SL; Thompson KS; Akhtar S
J Drug Target; 2000; 7(5):373-82. PubMed ID: 10721799
[TBL] [Abstract][Full Text] [Related]
37. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice.
Fischer D; Osburg B; Petersen H; Kissel T; Bickel U
Drug Metab Dispos; 2004 Sep; 32(9):983-92. PubMed ID: 15319340
[TBL] [Abstract][Full Text] [Related]
38. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty.
Gunn J; Holt CM; Francis SE; Shepherd L; Grohmann M; Newman CM; Crossman DC; Cumberland DC
Circ Res; 1997 Apr; 80(4):520-31. PubMed ID: 9118483
[TBL] [Abstract][Full Text] [Related]
39. Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.
Zhao Q; Matson S; Herrera CJ; Fisher E; Yu H; Krieg AM
Antisense Res Dev; 1993; 3(1):53-66. PubMed ID: 8495106
[TBL] [Abstract][Full Text] [Related]
40. Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization.
Yaida Y; Nowak TS
Regul Pept; 1995 Oct; 59(2):193-9. PubMed ID: 8584754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
